A multicenter phase I/II study of irinotecan (CPT-11) and S-1 combination chemotherapy for metastatic colorectal cancer (CRC)
收藏NIAID Data Ecosystem2026-03-06 收录
官方服务：
资源简介：
Interventions: Irinotecan+S-1, repeated every 3 weeks. Primary outcome(s): Phase I : recommended dose Phase I I: Response rate Study Design: Single arm Non-randomized
创建时间：
2004-02-15
